TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT05000216

COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

Cause of deathSlow enrollment Automatic label, confidence 0.5, unverified. How labels are made.
“The study was closed due to continued enrollment hurdles.”

The sponsor’s own words in the registry.

Life of this trial

202120222023202420252026Registered2021-08-06Started2021-08-13Primary completion2023-06-22Stopped2024-03-28Results posted2025-08-22

Vital statistics

Status
Terminated
Phase
Phase 2
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Sponsor type
US National Institutes of Health
Conditions
Rheumatoid Arthritis (RA); Systemic Lupus Erythematosus (SLE); Pemphigus Vulgaris; Multiple Sclerosis (MS); Systemic Sclerosis (SSc); Pediatric SLE
Interventions
Moderna mRNA-1273; BNT162b2; Ad26.COV2.S; Continue IS (MMF or MPA); Continue IS (MTX); Continue IS (B cell depletion therapy)
Participants
258
Sites
29
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.